Health TeraImmune Presented Research on TREGable™ Technology at Globe News Wire Nov 19, 2022 GERMANTOWN, Md., Nov. 18, 2022 (GLOBE NEWSWIRE) -- TeraImmune, Inc., a biotechnology company focused on the discovery and development of novel Treg-based cell therapies for autoimmune diseases, announced today that it presented data…